Related Experiment Video
Updated: Jun 21, 2025

08:56
Characterization of Thymic Settling Progenitors in the Mouse Embryo Using In Vivo and In Vitro Assays
Published on: June 9, 2015
8.3K
Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous FOXN1 Mutations
Kelsey Voss1, Todd Bartkowiak1,2, Allison E Sewell1
1Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Immunohorizons
|July 15, 2024
Summary
Forkhead box N1 (FOXN1) variants impact T cell development. This study examines a specific FOXN1 variant in fraternal twins, revealing mutation-specific pathogenicity and evolving immune phenotypes over time.
Area of Science:
- Immunology
- Genetics
- Developmental Biology
Background:
- The transcription factor FOXN1 is crucial for thymic epithelial development and T cell maturation.
- Heterozygous FOXN1 variants can cause T cell lymphopenia at birth, with potential for recovery.
- The long-term immune reconstitution in these patients, particularly CD4+ T cell recovery, remains incompletely understood.
Observation:
- This study investigates the immune phenotypes of fraternal twins with low TCR excision circles and a heterozygous FOXN1 variant (c.1205del, p.Pro402Leufs*148).
- The immune profiles of the twins and their father, who carries the same variant, were analyzed to observe changes over time.
- The transcriptional activity and DNA binding of the identified heterozygous FOXN1 variant were characterized in vitro.
Findings:
- The heterozygous FOXN1 variant exhibited differential effects on the transcriptional activity of various target genes.
- The study observed evolving immune phenotypes in individuals with the same FOXN1 variant, suggesting dynamic changes in the immune environment.
- FOXN1 haploinsufficiency may contribute to thymic defects and T cell lymphopenia, but variant pathogenicity appears mutation-specific.
Implications:
- Understanding mutation-specific pathogenicity of FOXN1 variants is crucial for predicting long-term health risks, including infection and autoimmunity.
- Characterizing the transcriptional regulation impacted by FOXN1 variants can inform clinical decisions and the potential need for targeted therapeutics.
- This research highlights the complexity of immune reconstitution in FOXN1 variant carriers and the importance of longitudinal studies.

